| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.53B | 150.66B | 151.31B | 153.52B | 132.22B | 122.18B |
| Gross Profit | 31.92B | 31.66B | 30.33B | 29.45B | 27.35B | 22.38B |
| EBITDA | 20.22B | 17.25B | 15.97B | 13.15B | 13.80B | 9.12B |
| Net Income | 12.25B | 9.01B | 6.74B | 5.52B | 5.60B | 2.21B |
Balance Sheet | ||||||
| Total Assets | 188.47B | 190.53B | 192.79B | 174.09B | 167.28B | 170.43B |
| Cash, Cash Equivalents and Short-Term Investments | 15.84B | 15.19B | 16.16B | 10.39B | 14.12B | 22.12B |
| Total Debt | 10.27B | 10.95B | 12.34B | 15.41B | 13.20B | 22.99B |
| Total Liabilities | 67.30B | 69.34B | 74.71B | 71.18B | 69.87B | 75.42B |
| Stockholders Equity | 119.86B | 119.81B | 116.85B | 101.33B | 96.02B | 93.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.46B | 8.27B | -2.02B | 5.76B | 2.69B |
| Operating Cash Flow | 0.00 | 11.05B | 12.86B | 2.52B | 9.25B | 8.07B |
| Investing Cash Flow | 0.00 | -2.99B | -387.00M | -2.97B | -3.34B | -3.26B |
| Financing Cash Flow | 0.00 | -9.04B | -6.95B | -3.58B | -14.06B | -1.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥558.47B | 12.74 | 13.63% | 1.95% | -1.33% | 9.21% | |
75 Outperform | ¥145.38B | 9.78 | ― | 2.66% | -1.63% | 67.13% | |
73 Outperform | ¥105.82B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
67 Neutral | ¥17.43B | 23.32 | ― | 2.41% | -4.23% | -5.96% | |
65 Neutral | ¥243.97B | 14.72 | 8.35% | 2.73% | 3.35% | 810.44% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥306.87B | -15.81 | -20.43% | 3.72% | -8.20% | ― |